Lets patients with severe illnesses try personalized experimental treatments not yet fully approved.
This bill would expand the "Right to Try" law, allowing patients with life-threatening diseases or severely debilitating illnesses to request access to experimental medical treatments tailored to their unique genetic profile. Patients would need a doctor's certification and special informed consent, but manufacturers would not be required to provide these treatments.
Today, the "Right to Try" law allows patients with life-threatening diseases to access certain experimental drugs if they've exhausted approved options and can't join a clinical trial. This bill would expand that law by creating a new category for "investigational individualized medical treatments," which are personalized based on a patient's unique genetic profile. Patients with life-threatening or severely debilitating illnesses would be able to request these treatments, with different eligibility rules and a special consent process.
HR 9190 · 119th Congress · June 8, 2026 · AI Summary by gemini-2.5-flash · 9/10
Sign in to see your representatives' phone numbers